December 21, 2022
1 min read

Indian firm culpable for cough syrup deaths, says Gambia panel

The panel added that the exact scientific cause of the children’s deaths was still under investigation…reports Asian Lite News

A parliamentary committee in The Gambia has recommended prosecution of an Indian manufacturer of cough syrups suspected of causing the deaths of at least 70 children in the West African country.

After weeks of investigation, the Gambian parliamentary committee has now recommended that authorities should take tough measures, including banning all Maiden Pharmaceuticals products in the country and taking legal action against the firm, reports the BBC.

“The findings remain the same with the previous reports which indicates that Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup were contaminated with diethylene glycol and ethylene glycol,” the parliamentary committee said in its report.

Diethylene glycol and ethylene glycol are toxic to humans and could be fatal if consumed. But the panel added that the exact scientific cause of the children’s deaths was still under investigation.

The committee also wanted the country’s Medicine Control Agency to ensure all medicines imported into the country are properly registered and background checks conducted on manufacturers, including visiting their facilities, reports the BBC.

The report also revealed inadequacies in the country’s healthcare system urging the government to strengthen it and provide better equipment and medicines to hospitals.

In late July, The Gambia detected an increase in cases of acute kidney injury among children under the age of five.

The government later said around 69 children had died from these injuries.

The WHO then identified four of the Maiden Pharmaceuticals’ medicines as potentially linked to the deaths of the Gambian children and issued a global alert.

But Maiden Pharmaceuticals had denied the allegations, the BBC reported.

Government labs in India said their tests on the syrups found that they were “complying with specifications”.

An Indian official said last week that the WHO was “presumptuous” in blaming the syrups.

But the global health body told the BBC it was only following its mandate and “stands by the action taken”.

ALSO READ: India offers migrant training to be model residents in Gulf

Previous Story

‘Film making is voice, but it’s also craft and versatility’

Next Story

Venus Williams receives wild card for ASB Classic

Latest from -Top News

Trump Targets BRICS Allies with New Tariff

This move coincides with the ongoing BRICS summit being held in Rio de Janeiro, Brazil…reports Asian Lite News US President Donald Trump has announced that an additional 10 per cent tariff will

BRICS Endorses India’s Stand on Terror

The treaty proposed by India within the UN framework aims to provide a comprehensive legal basis for combating terrorism….reports Asian Lite News The leaders’ joint statement, issued after the 17th BRICS summit

BRICS Slams US Tariff Hikes

The leaders criticised developed nations for using environmental issues to justify trade restrictions on developing countries….reports Asian Lite News Rio de Janeiro, July 7 (IANS) Embroiled in a trade war launched by

US Tariffs Pushed to August Amid Talks

In April, Trump announced a base tariff of 10 per cent on most of America’s trading partners and thereafter additional duties ranging up to 50 per cent….reports Asian Lite News US President

Indonesia Joins BRICS Bloc

This year’s BRICS Summit saw an expanded format, reflecting the grouping’s growing relevance in international affairs….reports Asian Lite News Prime Minister Narendra Modi formally welcomed Indonesian President Prabowo Subianto into the BRICS
Go toTop

Don't Miss

The Gambia celebrates its National Day at Expo 2020

Expo 2020 Dubai today celebrated the National Day of Gambia,

India-Gambia ready to refurbish governance reforms

The step will be taken as the Union Cabinet on